511 related articles for article (PubMed ID: 32024694)
1. A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2).
Hartman Z; Geldenhuys WJ; Agazie YM
J Biol Chem; 2020 Mar; 295(11):3563-3575. PubMed ID: 32024694
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling.
Agazie YM; Hayman MJ
Mol Cell Biol; 2003 Nov; 23(21):7875-86. PubMed ID: 14560030
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism for SHP2 in promoting HER2-induced signaling and transformation.
Zhou X; Agazie YM
J Biol Chem; 2009 May; 284(18):12226-34. PubMed ID: 19261604
[TBL] [Abstract][Full Text] [Related]
4. Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling.
Keilhack H; Tenev T; Nyakatura E; Godovac-Zimmermann J; Nielsen L; Seedorf K; Böhmer FD
J Biol Chem; 1998 Sep; 273(38):24839-46. PubMed ID: 9733788
[TBL] [Abstract][Full Text] [Related]
5. A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation.
Montagner A; Yart A; Dance M; Perret B; Salles JP; Raynal P
J Biol Chem; 2005 Feb; 280(7):5350-60. PubMed ID: 15574420
[TBL] [Abstract][Full Text] [Related]
6. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
7. Time-resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling.
Vemulapalli V; Chylek LA; Erickson A; Pfeiffer A; Gabriel KH; LaRochelle J; Subramanian K; Cao R; Stegmaier K; Mohseni M; LaMarche MJ; Acker MG; Sorger PK; Gygi SP; Blacklow SC
Elife; 2021 Mar; 10():. PubMed ID: 33755016
[TBL] [Abstract][Full Text] [Related]
8. EGFR-activated Src family kinases maintain GAB1-SHP2 complexes distal from EGFR.
Furcht CM; Buonato JM; Lazzara MJ
Sci Signal; 2015 May; 8(376):ra46. PubMed ID: 25969544
[TBL] [Abstract][Full Text] [Related]
9. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
Fan YX; Wong L; Deb TB; Johnson GR
J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
[TBL] [Abstract][Full Text] [Related]
10. Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated Signaling.
Wang Q; Pan W; Wang S; Pan C; Ning H; Huang S; Chiu SH; Chen JL
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361428
[TBL] [Abstract][Full Text] [Related]
11. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
12. Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells.
Bhattacharyya S; Feferman L; Han X; Ouyang Y; Zhang F; Linhardt RJ; Tobacman JK
J Biol Chem; 2018 Jul; 293(28):11076-11087. PubMed ID: 29794138
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
15. Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2.
Sturla LM; Amorino G; Alexander MS; Mikkelsen RB; Valerie K; Schmidt-Ullrichr RK
J Biol Chem; 2005 Apr; 280(15):14597-604. PubMed ID: 15708852
[TBL] [Abstract][Full Text] [Related]
16. Development of an efficient "substrate-trapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates.
Agazie YM; Hayman MJ
J Biol Chem; 2003 Apr; 278(16):13952-8. PubMed ID: 12582165
[TBL] [Abstract][Full Text] [Related]
17. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor.
Ren Y; Meng S; Mei L; Zhao ZJ; Jove R; Wu J
J Biol Chem; 2004 Feb; 279(9):8497-505. PubMed ID: 14665621
[TBL] [Abstract][Full Text] [Related]
18. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.
Li X; Huang Y; Jiang J; Frank SJ
Cell Signal; 2008 Nov; 20(11):2145-55. PubMed ID: 18762250
[TBL] [Abstract][Full Text] [Related]
19. Mutation of Thr466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutant.
Merritt R; Hayman MJ; Agazie YM
Biochim Biophys Acta; 2006 Jan; 1763(1):45-56. PubMed ID: 16413071
[TBL] [Abstract][Full Text] [Related]
20. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
